Quality of life and pruritus over 52 weeks of apremilast treatment in biologic-naive patients with moderate plaque psoriasis: Results of a real-world, multicenter, prospective study in Greece (APRAISAL)

被引：0
|
作者：
Ioannides, Dimitrios [1 ,2 ]
Tampouratzi, Eleftheria [3 ]
Rigopoulos, Dimitrios [4 ]
Drosos, Alexandros [5 ]
Rovithi, Evangelia [6 ]
Papadavid, Evangelia [7 ]
Papageorgiou, Marina [8 ]
Bassukas, Ioannis [9 ]
Zafiriou, Efterpi [10 ]
Panagakis, Pantelis [11 ]
机构：
[1] Aristotle Univ Thessaloniki, Univ Dept Dermatol 1, Thessaloniki, Greece
[2] Hosp Venereal Skin Dis Thessaloniki, Thessaloniki, Greece
[3] Piraeus Reg Gen Hosp Tzaneio, Dermatol Unit, Piraeus, Greece
[4] Natl Kapodistrian Univ Athens, Dept Dermatol & Venereol 1, Athens, Greece
[5] Gen Hosp Xanthi, Dept Dermatol, Athens, Greece
[6] Venizeleio Pananeio Gen Hosp Heraklion, Dept Dermatol & Venereol, Iraklion, Greece
[7] Natl Kapodistrian Univ Athens, Attikon Univ Gen Hosp, Dept Dermatol & Venereol 2, Athens, Greece
[8] Hosp Venereal & Skin Dis Thessaloniki, State Dept Dermatol, Thessaloniki, Greece
[9] Univ Ioannina, Dept Skin & Venereal Dis, Ioannina, Greece
[10] Univ Gen Hosp Larissa, Univ Clin Dermatol, Larisa, Greece
[11] Andreas Sygros Hosp Athens, Dermatol & Venereol Dept NHS, Athens, Greece
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
27506
引用
收藏
页码：AB150 / AB150
页数：1
相关论文
共 50 条
  • [41] Persistence of treatment with biologics for patients with psoriasis: a real-world analysis of 16 545 biologic-naive patients from the French National Health Insurance database (SNIIRAM)
    Sbidian, E.
    Mezzarobba, M.
    Weill, A.
    Coste, J.
    Rudant, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (01) : 86 - 93
  • [42] Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study
    Li, Ying
    Lv, Chengzhi
    Dang, Lin
    Lin, Bingjiang
    Tao, Juan
    Zhang, Chunlei
    Zhou, Xiaoyong
    Ma, Han
    Lu, Yi
    Chen, Rong
    Li, Jinnan
    Dou, Guanshen
    Liang, Yunsheng
    Liang, Yanhua
    Shi, Yuling
    DERMATOLOGY AND THERAPY, 2024, 14 (04) : 907 - 918
  • [43] Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study
    Ying Li
    Chengzhi Lv
    Lin Dang
    Bingjiang Lin
    Juan Tao
    Chunlei Zhang
    Xiaoyong Zhou
    Han Ma
    Yi Lu
    Rong Chen
    Jinnan Li
    Guanshen Dou
    Yunsheng Liang
    Yanhua Liang
    Yuling Shi
    Dermatology and Therapy, 2024, 14 : 907 - 918
  • [44] Quality of life benefit and clinical predictors of complete skin clearance in psoriasis: a multicenter, prospective, real-world study
    Jiang, Yuxiong
    Li, Ying
    Huang, Dawei
    Zhong, Xiaoyuan
    Yu, Qian
    Liang, Yanhua
    Dang, Lin
    Lv, Chengzhi
    Lin, Binjiang
    Zhang, Furen
    Liang, Yunsheng
    Lu, Jiajing
    Shi, Yuling
    DERMATOLOGY, 2023, 239 (05) : 802 - 810
  • [45] TREATMENT DISCONTINUATION, FLARES, AND HOSPITALIZATIONS AMONG BIOLOGIC-NAiVE PATIENTS WITH IBD OVER THE FIRST YEAR OF TREATMENT: A "REAL-WORLD" COMPARATIVE EFFECTIVENESS STUDY OF VEDOLIZUMAB VERSUS INFLIXIMAB
    Patel, Haridarshan
    Raluy-Callado, Mireia
    Berger, Ariel
    Curtis, Rebecca
    Khalid, Javaria Mona
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S78 - S79
  • [46] Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn's disease patients: results from the EVOLVE study
    Bressler, B.
    Mantzaris, G.
    Silverberg, M.
    Zezos, P.
    Stein, D.
    Colby, C.
    Lissoos, T.
    Lopez, C.
    Natsios, A.
    Radulescu, G.
    Patel, H.
    Demuth, D.
    Yarur, A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S427 - S428
  • [47] REAL-WORLD CLINICAL EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND USTEKINUMAB IN BIOLOGIC-NAIVE PATIENTS WITH CROHN'S DISEASE: RESULTS FROM THE EVOLVE EXPANSION STUDY
    Ferrante, Marc
    Christensen, Britt
    Bressler, Brian
    Brett, Neil R.
    Bassel, Marielle
    Kamble, Pravin
    Adsul, Shashi
    Gianchetti, Lauren
    Scharl, Michael M.
    GASTROENTEROLOGY, 2023, 164 (06) : S5 - S5
  • [48] REAL-WORLD EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND ANTI-TNF IN BIOLOGIC-NAIVE CROHN'S DISEASE PATIENTS: RESULTS FROM THE EVOLVE STUDY
    Mantzaris, Gerassimos J.
    Yarur, Andres J.
    Silverberg, Mark S.
    Zezos, Petros
    Stein, Dara
    Kim, Hankyul
    Lissoos, Trevor
    Lopez, Claudia
    Natsios, Athanasios
    Radulescu, Gabriela
    Patel, Haridarshan
    Demuth, Dirk
    Bressler, Brian
    GASTROENTEROLOGY, 2019, 156 (06) : S638 - S638
  • [49] Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with Crohn's disease: Results from the EVOLVE Expansion study
    Ferrante, M.
    Christensen, B.
    Bressler, B.
    Brett, N.
    Bassel, M.
    Kamble, P.
    Adsul, S.
    Gianchetti, L.
    Scharl, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 116 - 117
  • [50] Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with Crohn's disease: Results from the EVOLVE Expansion study
    Ferrante, M.
    Christensen, B.
    Bressler, B.
    Brett, N.
    Bassel, M.
    Kamble, P.
    Adsul, S.
    Gianchetti, L.
    Scharl, M.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 768 - 769
12345